Cognito Raises $105M Series C Round To Fund Alzheimer’s Device, Adds Brain Health Partners

 
• By Marion Webb
  
Cognito Therapeutics closed a new funding round to advance its Alzheimer’s headset Spectris toward FDA De Novo submission and planned 2027 launch. (Cognito Therapeutics)

More from Financing

More from Business